申请人:Takeda Chemical Industries, Ltd.
公开号:EP0092239A2
公开(公告)日:1983-10-26
Novel oxazole derivatives of the formula
wherein R1 is hydrogen or a straight, branched or cyclic alkyl group of 1 to 6 carbon atoms, R2 is hydrogen, halogen, trifluoromethyl, or a straight, branched or cyclic alkylthio of 1 to 3 carbon atoms, and n is 1 or 2 or pharmaceutically acceptable salts or esters thereof are synthesized through several routes. The derivatives have hypoglycemic, glucose tolerance improving and insulin sensitivity increasing activities and are of value as antidiabetic drugs.
式中的新型噁唑衍生物
其中 R1 为氢或 1 至 6 个碳原子的直链、支链或环状烷基,R2 为氢、卤素、三氟甲基或 1 至 3 个碳原子的直链、支链或环状烷硫基,n 为 1 或 2 或其药学上可接受的盐或酯,这些衍生物是通过多种途径合成的。这些衍生物具有降血糖、改善葡萄糖耐量和提高胰岛素敏感性的活性,具有抗糖尿病药物的价值。